Skip to main navigation Skip to search Skip to main content

Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science